Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.
about
Isotretinoin use and the risk of inflammatory bowel disease: a case-control studyMurine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseSustaining Research Networks: the Twenty-Year Experience of the HMO Research NetworkThiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.Increased risk for non-melanoma skin cancer in patients with inflammatory bowel diseaseSuboptimal rates of cervical testing among women with inflammatory bowel diseaseRisk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel diseaseTopiramate use does not reduce flares of inflammatory bowel diseaseStem cells as potential therapeutic targets for inflammatory bowel disease.Utilization of healthcare resources by U.S. children and adults with inflammatory bowel diseaseRisk of diagnosed fractures in children with inflammatory bowel diseases.Probiotics for maintaining remission of ulcerative colitis in adults.Pros and cons of medical management of ulcerative colitis.Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study.Targeted 25-hydroxyvitamin D3 1α-hydroxylase adoptive gene therapy ameliorates dss-induced colitis without causing hypercalcemia in micePrenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease.Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.Increased risk of pneumonia among patients with inflammatory bowel disease.Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes.Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach.Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.Can health care databases be used to identify incident cases of osteonecrosis?Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States.Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel diseaseIncreased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study.Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit.Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.Positioning Therapy for Ulcerative Colitis.Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis.The prevalences of some rheumatic diseases in western Turkey: Havsa study.Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.Inflammatory bowel disease aggregation in Utah kindreds.
P2860
Q24621195-32AEC300-7C65-4036-9404-B81BA8A77EB8Q26863622-DF49A72F-5749-471D-A10D-9075DFD0F2E2Q28651796-F21ACC11-9010-4F51-9A51-B73597407B3FQ33694542-1088D4C1-8116-4AF4-9B2A-D8D820EEC129Q33727211-91421747-20EF-4FAE-B967-DD8C64CC29E2Q33727220-59B0B352-606C-449E-B99E-CB203019A041Q33786255-5378FF65-18A2-470F-8865-712E0081A362Q33807261-B08811F8-EEEF-4153-9701-4EDB13AB75A2Q33975300-264AC4FD-DD73-4EA4-A620-2A87BCC85E5AQ34233590-9D163F65-37E2-42D5-9294-68B91B868F70Q34448516-001FB354-2636-4346-9E93-0B5EFE84F08EQ34616408-C627A729-D716-4744-9C32-731C78255BC0Q35100726-3B441A18-31DD-49A1-933C-E1420F3CF252Q35541718-A092FD49-7971-4AD4-8DE5-6CC84BA801CCQ35653235-B23544AE-AA8C-439A-AEA8-45330398702CQ35684726-6B217CF5-3093-45E8-845F-7721D45E44F3Q36174814-6DB23883-B9C3-4390-A236-0C3E83046A3CQ36219145-F2C117AB-2500-4EA9-BECE-866696355299Q36622034-E20C8422-F40C-4B66-AB99-768EEF34FAC6Q36874416-FBC8A134-F464-4692-87D3-44F90C957B71Q36881504-FBAF2CA9-58DB-476E-A799-2E218DB137F8Q37035957-4B570E01-4F07-40CF-BC65-05382B46AE86Q37146476-8156AA3C-BDA5-423E-BF96-C1E5EA75E386Q37270854-88A1E217-52FD-4339-9830-105A264DD686Q37378129-BB763FEC-5696-434A-A41D-A0F72E10A7EFQ37429242-977772EA-EE98-49A7-9AEC-D267D6A786EAQ37456737-290160D1-7EA4-45F4-AFF2-425FDE1A5BD3Q37540222-AC08598A-33C5-4F7B-8B2E-C31EC114E0E0Q37678171-BC2DCD5A-AA66-4588-AB57-5322A974219BQ37721906-E5D6F4E0-6256-490E-931D-92197BAC7195Q37822501-444B6263-7DD5-42FB-8C25-05C8B7F0501DQ38542903-01C560CF-C6B4-4242-AAD8-8A9205E1D27BQ38601056-8DCF1055-BDF9-480A-B9C6-8B782AC0C8F0Q39044550-8A2BE387-FA94-4C35-AE12-2928A2471749Q39251794-F0827EE6-E4F8-432A-9008-312AB450D70EQ40337416-372B5AEE-37FF-43D8-B437-99DF37E088C9Q42223966-BF0128F1-04D9-4428-936E-0E6FE58ED4B4Q43674654-AD36F9A8-A18B-4CB0-A571-270EC2A90EB7Q45966647-1D185FB7-B546-4CF8-8FDE-8377F1D06C6BQ46218880-E312A309-7650-4250-A194-45B54D61FBD4
P2860
Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Estimation of the period preva ...... tpatient pharmacy dispensings.
@ast
Estimation of the period preva ...... tpatient pharmacy dispensings.
@en
type
label
Estimation of the period preva ...... tpatient pharmacy dispensings.
@ast
Estimation of the period preva ...... tpatient pharmacy dispensings.
@en
prefLabel
Estimation of the period preva ...... tpatient pharmacy dispensings.
@ast
Estimation of the period preva ...... tpatient pharmacy dispensings.
@en
P2093
P2860
P356
P1476
Estimation of the period preva ...... tpatient pharmacy dispensings.
@en
P2093
Deborah Hiatt
Eli J Korner
James E Allison
Jennifer Elston Lafata
K Arnold Chan
Lisa J Herrinton
Richard Platt
Siobhán O'Connor
Susan E Andrade
P2860
P304
P356
10.1002/IBD.20021
P577
2007-04-01T00:00:00Z